• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series.

作者信息

Morecroft Renée, Phillipps Jordan, Barozinsky Kaiden, Jones Susan, Sun Lulu, Crites Danielle, Butt Omar, Ansstas George, Grierson Patrick, Johanns Tanner M, Zhou Alice

机构信息

Department of Internal Medicine, HCA Florida Orange Park Hospital, Orange Park, Florida.

Department of Dermatology, Mayo Clinic, Jacksonville, Florida.

出版信息

JAAD Case Rep. 2025 Jul 12;64:128-134. doi: 10.1016/j.jdcr.2025.04.047. eCollection 2025 Oct.

DOI:10.1016/j.jdcr.2025.04.047
PMID:40948682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12423659/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bca/12423659/769638642303/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bca/12423659/e6ef5c4eb474/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bca/12423659/769638642303/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bca/12423659/e6ef5c4eb474/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bca/12423659/769638642303/gr2.jpg

相似文献

1
Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series.外分泌腺癌与同源重组修复癌症易感基因：病例系列
JAAD Case Rep. 2025 Jul 12;64:128-134. doi: 10.1016/j.jdcr.2025.04.047. eCollection 2025 Oct.
2
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.同源重组基因中的种系和体细胞突变可预测卵巢癌、输卵管癌和腹膜癌对铂类药物的反应及生存率。
Clin Cancer Res. 2014 Feb 1;20(3):764-75. doi: 10.1158/1078-0432.CCR-13-2287. Epub 2013 Nov 15.
3
Targeting CDK9 With Harmine Induces Homologous Recombination Deficiency and Synergizes With PARP Inhibitors in Ovarian Cancer.用骆驼蓬碱靶向细胞周期蛋白依赖性激酶9可诱导同源重组缺陷，并在卵巢癌中与聚（ADP-核糖）聚合酶抑制剂协同作用。
Phytother Res. 2025 Aug;39(8):3648-3663. doi: 10.1002/ptr.70021. Epub 2025 Jul 9.
4
Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.早发性/家族性前列腺癌患者中同源重组修复基因的遗传图谱
Genes Chromosomes Cancer. 2023 Dec;62(12):710-720. doi: 10.1002/gcc.23190. Epub 2023 Jul 12.
5
The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review.PARP 抑制剂在卵巢上皮性癌中的作用机制、疗效及临床意义的分子机制：系统评价。
Int J Mol Sci. 2022 Jul 23;23(15):8125. doi: 10.3390/ijms23158125.
6
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.具有 SET 样形态的卵巢高级别浆液性癌：一种同源重组缺陷型肿瘤。
Hum Pathol. 2023 Nov;141:15-21. doi: 10.1016/j.humpath.2023.08.010. Epub 2023 Sep 9.
7
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities.同源重组修复缺陷型转移性前列腺癌：新的治疗机会。
Int J Mol Sci. 2024 Apr 24;25(9):4624. doi: 10.3390/ijms25094624.
8
Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.甲氨蝶呤抑制肿瘤细胞 RAD51 表达和同源重组。
J Cancer Res Clin Oncol. 2012 May;138(5):811-8. doi: 10.1007/s00432-011-1132-8. Epub 2012 Jan 25.
9
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer.DNA 修复基因改变与转移性去势抵抗性前列腺癌患者对 PARP 抑制剂的反应。
J Natl Compr Canc Netw. 2018 Aug;16(8):933-937. doi: 10.6004/jnccn.2018.7020.
10
JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction.JPI-547，一种PARP/端锚聚合酶双重抑制剂，对具有同源重组修复缺陷或Wnt成瘾性的胰腺癌显示出抗肿瘤活性。
Int J Biol Sci. 2025 Aug 22;21(12):5460-5475. doi: 10.7150/ijbs.113726. eCollection 2025.

本文引用的文献

1
Homologous Recombination Deficiency (HRD) in Cutaneous Oncology.皮肤肿瘤的同源重组缺陷（HRD）。
Int J Mol Sci. 2023 Jun 28;24(13):10771. doi: 10.3390/ijms241310771.
2
Targeting DNA damage response pathways in cancer.靶向癌症中的DNA损伤反应通路。
Nat Rev Cancer. 2023 Feb;23(2):78-94. doi: 10.1038/s41568-022-00535-5. Epub 2022 Dec 5.
3
Diagnosis and Management of Porocarcinoma.汗孔癌的诊断与管理
Cancers (Basel). 2022 Oct 25;14(21):5232. doi: 10.3390/cancers14215232.
4
Molecular pathology of skin adnexal tumours.皮肤附属器肿瘤的分子病理学
Histopathology. 2022 Jan;80(1):166-183. doi: 10.1111/his.14441.
5
Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.全外显子组测序在小汗腺汗孔瘤中显示出有希望的治疗策略。
Cancer Gene Ther. 2022 Jun;29(6):697-708. doi: 10.1038/s41417-021-00347-z. Epub 2021 May 27.
6
Update on Molecular Genetic Alterations of Cutaneous Adnexal Neoplasms.皮肤附属器肿瘤分子遗传学改变的最新进展。
Surg Pathol Clin. 2021 Jun;14(2):251-272. doi: 10.1016/j.path.2021.03.004.
7
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.遗传/家族性高风险评估：乳腺癌、卵巢癌和胰腺癌，第 2.2021 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
8
Germline Mutations in Cancers and Its Distinction From Somatic Mutations in Breast Cancers.癌症中的种系突变及其与乳腺癌体细胞突变的区别。
Front Genet. 2020 Aug 27;11:829. doi: 10.3389/fgene.2020.00829. eCollection 2020.
9
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer.DNA损伤修复缺陷作为转移性胰腺癌中FOLFIRINOX疗效的预测生物标志物。
J Gastrointest Oncol. 2019 Dec;10(6):1133-1139. doi: 10.21037/jgo.2019.09.12.
10
Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families.与生殖系致病性变异相关的癌症风险：一项对524个家庭的国际研究。
J Clin Oncol. 2020 Mar 1;38(7):674-685. doi: 10.1200/JCO.19.01907. Epub 2019 Dec 16.